1. Long periods of viral suppression shown to prevent cancer in aging HIV population
URLs go live when the embargo lifts
Early, sustained antiretroviral therapy (ART), which results in long-term viral suppression, helps to prevent AIDS-defining cancers and also non-AIDS-defining cancers, to a lesser degree. However, patients with long-term viral suppression still had excess cancer risk compared to uninfected patients. The study, published in Annals of Internal Medicine, is the first to examine the effects of prolonged periods of viral suppression and potential cancer prevention benefits for the aging population of persons living with HIV.
Persons with HIV are at increased risk for AIDS-defining cancers (Kaposi sarcoma, non-Hodgkin lymphoma, invasive cervical cancer) and non-AIDS-defining cancers (lung, larynx, melanoma, leukemia, etc.). Some of these cancers are known to be caused by viruses (certain anal, liver, Hodgkin lymphoma, etc.) that are common among persons with HIV. Viral suppression is a key component of HIV treatment, and studies have shown an association between prolonged viral suppression and decreased risk for some types of cancer. However, no studies have specifically focused on the effect of sustained viral suppression on overall cancer risk.
Researchers from the Stanford Center for Population Health Sciences compared cancer
Article originally posted at